ERBB2 and breast carcinoma: To this end, we performed a comprehensive review of the relevant literature published from 2010 until September 2022 by searching in the PubMed database using the following keywords: “HER2 Breast Cancer” AND “Treatment/drug resistance” OR “Novel/new therapy” OR “Clinical trial” OR “mechanism of resistance”.